
photo credit: Cedric Fauntleroy / Pexels
Key Takeaways
- Common medications like metformin and beta-blockers are being studied for their potential to slow cancer growth through biological pathways.
- Observational studies suggest promising links between these drugs and reduced cancer risk or improved survival outcomes.
- Randomized clinical trials have produced mixed results, highlighting the need for further research before clinical adoption.
- Mechanisms such as insulin regulation and stress hormone blocking may explain how these drugs influence cancer biology.
- Drug repurposing offers a cost-effective and faster pathway to expanding cancer treatment options using existing medications.









